Mandate

Vinge has advised Rotla on the sale of Centralpoint

Vinge advises Rotla B.V., a company controlled by Altor Fund IV and Kool Active B.V.,  in connection with the sale of Centralpoint Holding B.V., the leading IT value added reseller in the Benelux region, to Dustin.

The purchase price amounts to EUR 425 million on a cash and debt free basis and comprises of newly issued shares in Dustin and cash. The sale is subject to customary closing conditions, including merger control clearance from the Dutch competition authority.

Vinge’s team consisted of David Andersson (Capital Markets and Public M&A), Louise Brorsson Salomon and Seyran Sahin (Banking and Finance).

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026

Vinge has advised Resurs in connection with its strategic partnership with Kustom

Vinge has advised Resurs in connection with its strategic partnership with Kustom (formerly Klarna Checkout), a fast-growing player in the digital commerce sector. The partnership enables Resurs to accelerate its strategic development by offering a check-out solution to its merchants, built on Kustom’s market-leading infrastructure.
March 25, 2026